Tumor Chemosensitivity Conferred by Inserted Herpes Thymidine Kinase Genes: Paradigm for a Prospective Cancer Control Strategy

Cancer Research

Volumn 46, Issue 10, 1986, Pages 5276-5281

  Moolten, Frederick L ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THYMIDINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; CANCER CONTROL; CELL LINE; CLONOGENIC ASSAY; DRUG SENSITIVITY; GENE INSERTION; GENETIC ENGINEERING; HEREDITY; IN VITRO STUDY; MOSAICISM; MOUSE; NONHUMAN; PREVENTION; PRIORITY JOURNAL;

ACYCLOVIR; ANIMAL; ANTIVIRAL AGENTS; CELL LINE; DNA TRANSPOSABLE ELEMENTS; GANCICLOVIR; MALE; MICE; MICE, INBRED BALB C; MOSAICISM; NEOPLASMS, EXPERIMENTAL; SIMPLEXVIRUS; SUPPORT, U.S. GOV'T, NON-P.H.S.; THYMIDINE KINASE;

EID: 0022485359     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Yunis, J. J. The chromosomal basis of neoplasia. Science (Wash. DC), 221: 227-236, 1983.
2. Land, H., Parada, L. F., and Weinberg, R. A. Cellular oncogenes and multistep carcinogenesis. Science (Wash. DC), 222: 771-778, 1983.
3. Moolten, F. L. Letter to editor. Perspect. Biol. Med., 12: 169-171, 1968.
4. Moolten, F. L. Genetic mosaicism and the control of cancer. Med. Hy potheses, 2: 79-81, 1976.
5. McCulloch, E. A., and Till, J. E. The radiation sensitivity of normal mouse bone marrow cells, determined by quantitative marrow transplantation into irradiated mice. Radiât.Res., 13: 115-125, 1960.
6. McCulloch, E. A., and Till, J. E. The sensitivity of cells from normal mouse bone marrow to gamma radiation in vitro and in vivo. Radiât.Res., 16: 822-832, 1962.
7. Fialkow, P. J. Clonal origin of human tumors. Biochim. Biophys. Acta, 4SS: 283-321, 1976.
8. Miller, A. D., Eckner, R. J., Jolly, D. J., Friedmann, T., and Verma, I. M. Expression of a retrovirus encoding human HPRT in mice. Science (Wash. DC), 225: 630-632, 1984.
9. Dick, J. E., Magli, M. C., Huszar, D., Phillips, R. A., and Bernstein, A. Introduction of a selectable gene into primitive stem cells capable of long-term reconstitution of the hemopoietic system of WjW mice. Cell, 42: 71-79, 1985.
10. Keller, G., Paige, C., Gilboa, E., and Wagner, E. F. Expression of a foreign gene in myeloid and lymphoid cells derived from multipotent haematopoietic precursors. Nature (Lond.), 318: 149-154, 1985.
11. Eglitis, M. A., Kantoff, P., Gilboa, E., and Anderson, W. F. Gene expression in mice after high efficiency retroviral-mediated gene transfer. Science (Wash. DC), 230: 1395-1398, 1985.
12. Elion, G. B., Furman, P. A., Fyfe, J. A., de Miranda, P., Beauchamp, L., and Schaeffer, H. J. Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl)guanine. Proc. Nati. Acad. Sci. USA, 74: 5716-5720, 1977.
13. Nishiyama, Y., and Rapp, F. Anticellular effects of 9-(2-hydroxyethoxymethyl) guanine against herpes simplex virus-transformed cells. J. Gen. Virol., 45:227-230, 1979.
14. Furman, P. A., McGuirt, P. V., Keller, P. M., Fyfe, J. A., and Elion, G. B. Inhibition by acyclovir of cell growth and DNA synthesis of cells biochemi cally transformed with herpesvirus genetic information. Virology, 102: 420-430, 1980.
15. Davidson, R. L., Kaufman, E. R., Crumpacker, C. S. and Schnipper, L. E. Inhibition of herpes simplex virus transformed and nontransformed cells by acycloguanosine: mechanisms of uptake and toxicity. Virology, 113: 9-19, 1981.
16. Field, A. K., Davies, M. E., DeWitt, C., Perry, H. C., Liou, R., Germershausen, J., Karkas, J. D., Ashton, W. T., Johnston, D. B. R., and Tolman, R. L. 9-{[2-Hydroxy-l-(hydroxymethyl)ethoxyl]methyl|guanine: a selective in hibitor of herpes group virus replication. Proc. Nati. Acad. Sci. USA, 80: 4139-4143, 1983.
17. Smith, K. O., Galloway, K. S., Kennell, W. L., Ogilvie, K. K., and Radatus, B. K. A new nucleoside analog, 9-[[2-hydroxy-l-(hydroxymethyl)ethoxy] methyljguanine, highly active in vitro against herpes simplex virus types 1 and 2. Antimicrob. Agents Chemother., 22:55-61, 1982.
18. Smee, D. F., Martin, J. C., Verheyden, J. P. H., and Matthews, T. R. Antiherpesvirus activity of the acyclic nucleoside 9-( 1,3-dihydroxy-2-propoxymethyl) guanine. Antimicrob. Agents Chemother., 23: 676-682, 1983.
19. Oliver, S., Bubley, G., and Crumpacker, C. Inhibition of HSV-transformed murine cells by nucleoside analogs, 2'-NDG and 2'-nor-cGMP: mechanisms of inhibition and reversal by exogenous nucleosides. Virology, 145: 84-93, 1985.
20. Szybalski, W., Szybalska, E. H., and Ragni, G. Genetic studies with human cell lines. Nati. Cancer Inst. Monogr., 7: 75-88, 1962.
21. Littlefield, J. W. The use of drug-resistant markers to study the hybridization of mouse fibroblasts. Exp. Cell Res., 41: 190-196, 1966.
22. Hampar, B., Derge, J. G., Boyd, A. L., Tainsky, M. A., and Showalter, S. D. Herpes simplex virus (type 1) thymidine kinase gene does not transform cells morphologically. Proc. Nati. Acad. Sci. USA, 78: 2616-2619, 1981.
23. Godson, G. N., and Vapnek, D. A simple method of preparing large amounts of 0X174 RF I supercoiled DNA. Biochim. Biophys. Acta, 299: 516-520, 1973.
24. Weller, S. K., Aschman, D. P., Sacks, W. R., Coen, D. M., and Schaffer, P. A. Genetic analysis of temperature-sensitive mutants of HSV-1 : the combined use of complementation and physical mapping for cistron assignment. Vi rology, /JO: 290-305, 1983.
25. Goodenow, R. S., McMillan, M., Orn, A., Nicolson, M., Davidson, N., Frelinger, J. A., and Hood, L. Identification of a BALB/c H-2Ld gene by DNA-mediated gene transfer. Science (Wash. DC), 215:677-679, 1982.
26. Stephenson, J. R., and Aaronson, S. A. Antigenic properties of murine sarcoma virus-transformed BALB/3T3 non-producer cells. J. Exp. Med., 135: 503-515, 1972.
27. Brinster, R. L., Chen, H. Y., Trumbauer, M., Senear, A. W., Warren, R., and Palmiter, R. D. Somatic expression of herpes thymidine kinase in mice following injection of a fusion gene into eggs. Cell, 27: 223-231, 1981.
28. Summers, W. C., and Summers, W. P. (125I)Deoxycytidine used in a rapid, sensitive, and specific assay for herpes simplex virus type I thymidine kinase. J. Virol., 2*314-318, 1977.
29. Brecher, G., Smith, W. W., Wilson, D., and Fred, S. Kinetics of colchicineinduced hemopoietic recovery in irradiated mice. Radiât.Res., 30: 600-610, 1967.
30. Storer, J. B. Acute responses to ionizing radiation. In: E. L. Green (ed.), The Biology of the Laboratory Mouse, pp. 427-446. New York: McGraw-Hill, 1966.
31. Till, J. E., and McCulloch, E. A. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radial. Res., 14: 213-222, 1961.
32. Hooper, M. L., and Subak-Sharpe, J. H. Metabolic cooperation between cells. Int. Rev. Cytol., 69: 45-104, 1981.
33. Burton, D. I., Ansell, J. D., Gray, R. A., and Micklem, H. S. A stem cell for stem cells in murine haematopoiesis. Nature (Lond.), 298: 562-563, 1982.
34. Christy, B., and Scangos, G. Expression of transferred thymidine kinase genes is controlled by methylation. Proc. Nati. Acad. Sci. USA, 79: 6299-6303, 1982.
35. Clough. D. W., Kunkel, L. M., and Davidson, R. L. 5-Azacytidine-induced reactivation of a herpes simplex thymidine kinase gene. Science (Wash. DC), 216: 70-73, 1982.
36. Skipper, H. E., Schabel, F. M., Jr., and Wilcox, W. S. On the criteria and kinetics associated with “curability” of experimental leukemia. Experimental evaluation of potential anticancer agents. Cancer Chemother. Rep., 35: 3-111, 1964.
37. Stone, D., and Smith, S. L. The amino acid sequence of the trimethoprimresistant dihydrofolate reduc�asespecified in Escherichia coli by R-plasmid R67. J. Biol. Chem. 254:10857-10861, 1979.
38. Lloyd, R. S., Haidle, C. W., and Robberson, D. L. Bleomycin-specific fragmentation of double-stranded DNA. Biochemistry, 17:1890-1896,1978.
39. Hurley, L. H., Reynolds, V. L., Swenson, D. H., Petzold, G. L., and Scahill, T. A. Reaction of the antitumor antibiotic CC-1065 with DNA: structure of a DNA adduci with DNA sequence specificity. Science (Wash. DC), 226: 843-844, 1984.
40. Goodenow, R. S., Stroynowski, I., McMillan, M., Nicolson, M., Eakle, K., Slu-r, B. T., Davidson, N., and Hood, L. Expression of complete transplan tation antigens by mammalian cells transformed with truncated class I genes. Nature (Lond.), 301: 388-394, 1983.
41. Nowell, P. C. Preleukemias. Hum. Pathol., 12: 522-530, 1981.
42. Anderson, W. F. Prospects for human gene therapy. Science (Wash. DC), 226:401-409,1984.
43. Straus, M. J., and Goldin, A. Effects of priming dose schedules in Cytoxan treatment of mouse leukemia L1210. Proc. Soc. Exp. Biol. Med., 145:1132-1138, 1974.
44. Laster, W. R., Jr., Mayo, J. G., Simpson-Herren, L., Griswold, D. P., Jr., Lloyd, H. H., Schabel, F. M., Jr., and Skipper, H. E. Success and failure in the treatment of solid tumors. II. Kinetic parameters and “cell cure” of moderately advanced carcinoma 755. Cancer Chemother. Rep., 53:169-188, 1969.